Executive Director, U.S. Medical Affairs - Prescription Dermatology
Galderma is hiring for Executive Director, U.S. Medical Affairs - Prescription Dermatology in Boston. Executive level, $250k–$330k a year stated. First seen October 29, 2026; open as of November 13, 2026. Jobs taken straight from company career pages — no aggregator in between.
With Destava: How well do you fit? · Tailor my résumé · Write a cover letter
- Company
- Galderma
- Where
- Boston
- Level
- Executive
- Pay stated
- $250k–$330k a year
- First seen
- October 29, 2026
- Listed via
- Workday
What the posting says
With us, you have the ultimate opportunity to gain new and challenging work experiences and create an unparalleled, direct impact. The Executive Director, U.S. Medical Affairs, Prescription Dermatology, is the senior U.S. medical leader accountable for setting the strategic direction and ensuring excellence in execution for the Prescription Dermatology Medical Affairs franchise. This role leads the U.S. medical strategy across the product lifecycle, integrating scientific, clinical, patient, and market insights to support appropriate use and high-quality evidence generation. As a member of…
Read more and apply on Galderma's site
More jobs like this
Practice Supervisor, HVI Yawkey Center
Save to applyPrimary Care Medical Director-Brookside Community Health Center
Save to applyClinical Manager, Molecular Imaging
Save to applyAssociate Director of Education and Training, McLean Center for Metabolic Psychiatry
Save to apply
See all 321 Medical and Health Services Managers jobs in Boston
A search agent finds the jobs this list misses: the ones that mean the same without the same words. Have Destava watch for executive director, u.s. medical affairs - prescription dermatology jobs in Boston, new matches every morning on your own account.
This page includes information from the O*NET 31.0 Database by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA). Used under the CC BY 4.0 license. O*NET® is a trademark of USDOL/ETA.